Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neural Fiber Optic Systems is a private medical device company developing minimally invasive fiber optic systems to monitor blood flow and oxygenation in the spinal cord and brain. Its lead product, FLOXsp, is designed for short-term epidural placement before, during, and after surgical procedures in which the spinal cord is at risk of ischemic injury. The company positions its technology as a real-time monitoring solution intended to help prevent paralysis and other complications associated with spinal cord ischemia during aortic and major spine surgery. Neural Fiber Optic Systems has received FDA Breakthrough Device designation for FLOXsp and appears to operate as a very small, early-stage healthcare technology company based in Richardson, Texas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neural Fiber Optic Systems.